XML 78 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Combinations (Tables) (Gen-Probe Incorporated [Member])
9 Months Ended
Jun. 29, 2013
Gen-Probe Incorporated [Member]
 
Purchase Price Consideration

The purchase price consideration was as follows:

 

Cash paid

   $ 3,967,866   

Deferred payment

     1,655   

Fair value of stock options exchanged

     2,655   
  

 

 

 

Total purchase price

   $ 3,972,176   
  

 

 

 
Components of Purchase Price Allocation

The components of the preliminary purchase price allocation are as follows:

 

Cash

   $ 205,463   

Accounts receivable

     81,444   

Inventory

     153,416   

Property, plant and equipment

     274,095   

Other assets

     192,354   

Assets held-for-sale, net

     87,465   

Accounts payable

     (19,671

Accrued expenses

     (131,566

Other liabilities

     (19,648

Identifiable intangible assets:

  

Developed technology

     1,565,000   

In-process research and development

     227,000   

Customer contract

     585,000   

Trade names

     95,000   

Deferred income taxes, net

     (972,196

Goodwill

     1,649,020   
  

 

 

 

Purchase Price

   $ 3,972,176   
  

 

 

 
Schedule of Unaudited Pro Forma Information

The following unaudited pro forma information presents the combined financial results for the Company and Gen-Probe as if the acquisition of Gen-Probe had been completed as of the beginning of the fiscal year prior to the period of acquisition, September 26, 2010:

 

     Three Months Ended
June 23, 2012
    Nine Months Ended
June 23, 2012
 

Revenue

   $ 626,225      $ 1,881,561   

Net loss

   $ (10,041   $ (93,420

Basic and diluted net loss per common share

   $ (0.04   $ (0.35